ARCHIVES

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

DCBD Board Okays Concept Of Program Announcement To Stimulate Human Monoclonal Antibody Research

June 4, 1982

National Coalition An Education Group, Chairman Says

May 3, 1985